Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Myeloma Center
Explore this Website
Home
About Us
Toggle About Us menu options
Our Team
For Patients
Toggle For Patients menu options
About Multiple Myeloma, Amyloidosis, and Other Plasma Cell Disorders
Multiple Myeloma
Amyloidosis
Other Plasma Cell Disorders
Toggle Other Plasma Cell Disorders menu options
Precursor Conditions to Multiple Myeloma
Myeloma Signs and Symptoms
Amyloidosis Signs and Symptoms
Risk Factors for Multiple Myeloma and Other Plasma Cell Disorders
Diagnosing Multiple Myeloma and Other Plasma Cell Disorders
Multiple Myeloma and Plasma Cell Disorder Treatment
Understanding and Managing Side Effects
Your First Visit
Toggle Your First Visit menu options
Self-Referral
Support Groups and Helpful Links
Frequently Asked Questions
Referring Physicians
Toggle Referring Physicians menu options
Refer a Patient
Research and Clinical Trials
Toggle Research and Clinical Trials menu options
Basic and Translational Research
Bibliography
Contact Us
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
For Patients
Referring Physicians
Research and Clinical Trials
Contact Us
Home
Bibliography
Bibliography
Basic and Translational Research
Bibliography
Bibliography
Found 8 results
Author
Title
Type
[
Year
]
Filters:
Author
is
Mark, Tomer M
[Clear All Filters]
2018
Singh AD
,
Parmar S
,
Patel K
,
Shah S
,
Shore T
,
Gergis U
,
Mayer S
,
Phillips A
,
Hsu J-M
,
Niesvizky R
et al.
. 2018.
Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices.
.
Biol Blood Marrow Transplant. 24(2):288-293.
2017
Ely S
,
Forsberg P
,
Ouansafi I
,
Rossi A
,
Modin A
,
Pearse R
,
Pekle K
,
Perry A
,
Coleman M
,
Jayabalan D
et al.
. 2017.
Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive Patients.
.
Clin Lymphoma Myeloma Leuk. 17(12):825-833.
Mark TM
,
Guarneri D
,
Forsberg P
,
Rossi A
,
Pearse R
,
Perry A
,
Pekle K
,
Tegnestam L
,
Greenberg J
,
Shore T
et al.
. 2017.
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma.
.
Biol Blood Marrow Transplant. 23(6):930-937.
2015
Krishnan U
,
Mark TM
,
Niesvizky R
,
Sobol I
. 2015.
Pulmonary hypertension complicating multiple myeloma.
.
Pulm Circ. 5(3):590-7.
2014
Mark TM
,
Coleman M
,
Niesvizky R
. 2014.
Preclinical and clinical results with pomalidomide in the treatment of relapsed/refractory multiple myeloma.
.
Leuk Res. 38(5):517-24.
Mark TM
,
Bowman IA
,
Rossi AC
,
Shah M
,
Rodriguez M
,
Quinn R
,
Pearse RN
,
Zafar F
,
Pekle K
,
Jayabalan D
et al.
. 2014.
Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma.
.
Leuk Lymphoma. 55(12):2842-9.
2013
Mark TM
,
Reid W
,
Niesvizky R
,
Gergis U
,
Pearse R
,
Mayer S
,
Greenberg J
,
Coleman M
,
van Besien K
,
Shore T
. 2013.
A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma.
.
Biol Blood Marrow Transplant. 19(5):831-7.
Richardson PG
,
Mark TM
,
Lacy MQ
. 2013.
Pomalidomide: new immunomodulatory agent with potent antiproliferative effects.
.
Crit Rev Oncol Hematol. 88 Suppl 1:S36-44.